Corticosteroid-binding globulin
| GO Term |
|---|
| extracellular space |
| GO Term |
|---|
| glucocorticoid metabolic process |
| GO Term |
|---|
| serine-type endopeptidase inhibitor activity |
| steroid binding |
| Position | Description | PubMed ID | GlyTouCan ID | Source |
|---|---|---|---|---|
| 89 | N-linked (GlcNAc...) asparagine |
|
||
| 169 | N-linked (GlcNAc...) asparagine | |||
| 217 | N-linked (GlcNAc...) asparagine |
|
||
| 232 | N-linked (GlcNAc...) asparagine |
|
||
| 253 | N-linked (GlcNAc...) asparagine |
|
||
| 319 |
|
|||
| 320 | N-linked (GlcNAc...) asparagine |
|
| Pathway Name | Organism |
|---|---|
| Glucocorticoid biosynthesis | Mus musculus |
| Prednisone ADME | Mus musculus |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0090030 | corticosteroid-binding globulin deficiency |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.3.0
Last updated: August 4, 2025